BIOSENSE WEBSTER INC CARTO VIZIGO¿ 8.5F BI-DIRECTIONAL GUIDING SHEATH ¿MEDIUM; INTRODUCER, CATHETER
|
Back to Search Results |
|
Model Number D138502 |
Device Problem
Contamination /Decontamination Problem (2895)
|
Patient Problem
No Clinical Signs, Symptoms or Conditions (4582)
|
Event Date 07/06/2022 |
Event Type
malfunction
|
Manufacturer Narrative
|
Device investigation details: a picture was received as provided by the customer to aid in the investigational analysis.An evaluation was performed following biosense webster's procedures.According to the picture provided by the customer, a foreign material stain was observed on the cardboard tray, at this time it is not possible to determine the origin of the foreign material, however, if the device is returned in the future, a further investigation will be performed.A device history record was performed for the finished device batch number, and no internal actions were identified.The issue reported by the customer was confirmed based on the picture received.The device has not been returned for analysis and is not possible to assign a root cause based on the current evidence.If the device is received in the future, the product investigation will be performed and updated accordingly.As part of the quality process, all devices are manufactured, inspected, and released to approved specifications.Investigation findings code of ¿appropriate term/code not available¿ represents photo/video analysis.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.#: (b)(4).
|
|
Event Description
|
It was reported that a patient underwent a paroxysmal atrial fibrillation (afib) ablation procedure with a carto vizigo¿ 8.5f bi-directional guiding sheath ¿medium and an issue of foreign material was encountered.After opening the carto vizigo¿ 8.5f bi-directional guiding sheath ¿medium, there was a residue or fluid inside the packaging and on the dilator of the carto vizigo¿ 8.5f bi-directional guiding sheath ¿medium.They replaced the carto vizigo¿ 8.5f bi-directional guiding sheath ¿medium and the procedure continued.The issue was noticed before use.The foreign material was described as clear and oily.The sheath was not used on the patient.It is unknown how device was contaminated, residue was discovered immediately after opening packaging.No fluids had been dropped in the sterile field yet and the scrub had new and dry gloves on.
|
|
Manufacturer Narrative
|
On 10-aug-2022, the bwi product analysis lab received the complaint device for evaluation.The product analysis has begun but is not completed at this time.When the investigational analysis has been completed, a supplemental 3500a report will be submitted.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
|
|
Manufacturer Narrative
|
It was reported that a patient underwent a paroxysmal atrial fibrillation (afib) ablation procedure with a carto vizigo¿ 8.5f bi-directional guiding sheath ¿medium and an issue of foreign material was encountered.After opening the carto vizigo¿ 8.5f bi-directional guiding sheath ¿medium, there was a residue or fluid inside the packaging and on the dilator of the carto vizigo¿ 8.5f bi-directional guiding sheath ¿medium.They replaced the carto vizigo¿ 8.5f bi-directional guiding sheath ¿medium and the procedure continued.The issue was noticed before use.The foreign material was described as clear and oily.The sheath was not used on the patient.Device evaluation details: the product was returned to biosense webster inc (bwi) for evaluation and the evaluation has been completed.Bwi conducted a visual inspection of the returned device.Visual analysis of the returned sample revealed that no damage or anomalies were observed on the carto vizigo¿ 8.5f bi-directional guiding sheath ¿medium.The device was returned without its original package, therefore, an analysis to identify the composition the residue observed by the customer could not be performed.A manufacturing investigation was initiated with the supplier.However, information about the origin of the residue observed on the packaging card during the procedure is not manufacturing-attributable.As the packaging was not returned, the residue cannot be confirmed.A device history record evaluation was performed, and no internal action related to the reported complaint condition were identified.As part of biosense webster's quality process, all devices are manufactured, inspected, and released to approved specifications.Note: h6.Investigation findings code of ¿appropriate term/code not available (d17)¿ used to represent the inability to analyze the product returned based on the returned condition.If additional information is received regarding this event, a supplemental 3500a report will be submitted to the fda.Manufacturer's ref.# (b)(4).
|
|
Search Alerts/Recalls
|
|
|